Robin Kahn

Our research

Can children get rheumatic joint disease? Is it a life-long disease? Does my child really need all these drugs?!

These are the questions we hear every week when meeting families to children with newly diagnosed inflammatory joint disease. To get a chronic disease will have a major impact on your day-to-day life and suddenly you are different. You need medications, repeated doctors’ visits and you have pain.

- Why did I get this?!

In our research group, we try to answer these questions that patients and parents ask every day. We investigate the long-term prognosis and risk of comorbidities in children with inflammatory joint disease as well as the inflammatory pattern in the joint of these children. We will try to manipulate the immune-cells to switch from a pro-inflammatory state to a state of resolution and homeostasis.

Aims

Our overall aim is to improve the care of children with rheumatic diseases.

Strengths of the group

• Strong translational research with both clinical and preclinical cutting-edge experience 
• Close collaboration with patient partners and patient associations

Impact

Our research has directly affected the care and clinical guidelines for the care of individual with rheumatic disease. 

| Research Output

Affiliations

• Wallenberg Center for Molecular Medicine 
• Department of Pediatrics, Clinical Sciences Lund